Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1292
| Despition | Nkx2.2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1624 | Human EFNA1 Protein (AC1624) | 5 µg | inquiry |
| ACPP-1102 | Recombinant Human Eph Receptor A3 Protein (Fc Chimera 6xHis Tag) (AC1102) | 50 µg | inquiry |
| ACPP-1030 | Recombinant Human Acetylcholinesterase Protein (6×His Tag) (AC1030) | 50 µg | inquiry |
| ACPP-1755 | Human PDGFD Protein (AC1755) | 5 µg | inquiry |
| ACPP-1012 | Recombinant Human Ninjurin 1 Protein (Fc Tag) (AC1012) | 50 µg | inquiry |
| ACPP-1541 | Human OTOR Protein (AC1541) | 5 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1709 | Human GPC4 Protein (AC1709) | 2 µg | inquiry |
| ACPP-1161 | Recombinant Human DLK-1 Protein (6×His Tag) (AC1161) | 50 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.